| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |